528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Navient posted a strategy update presentation on its website on January 29, 2025, describing Phase 1 of a turnaround focused on cost reductions and capital allocation. The company estimates Phase 1 will cut shared and corporate expense by $119 million and lift legacy loan portfolio cash flows by about $1.5 billion, which it says could add about $1 per share in annual net income. Management plans a Phase 2 update in the second half of 2025, and these benefits are company estimates, not reported results.
Phase 1 reduces net shared and corporate expense from $323 million in 2023 to $204 million in 2025, a $119 million reduction, after the divestiture of the Business Processing Segment and outsourcing of loan servicing.
Estimated lifetime cash flow from legacy loan portfolios rises by about $1.5 billion, and net income rises by about $1 per share annually.
Navient's price to tangible book value is 0.6x, against a peer average of 2.2x, according to FactSet data as of January 14, 2025.
A Phase 2 strategy update is expected in the second half of 2025.
NetApp announced that Wissam Jabre, formerly CFO of Western Digital, will become Executive Vice President and Chief Financial Officer effective March 10, 2025, replacing Michael J. Berry, who previously announced his retirement. Berry will stay on as a senior advisor to help with the transition. The change puts a new principal financial officer in charge of NetApp's finances, with compensation terms set out in the filing.
Wissam Jabre, age 55, becomes EVP and CFO effective March 10, 2025, replacing Michael J. Berry
Jabre's base salary is $750,000, with a 130% annual incentive target
Jabre will receive a $6,565,500 bonus, subject to repayment if he leaves within 24 months
RenaissanceRe reported a fourth-quarter 2024 net loss attributable to common shareholders of $198.5 million, or $(3.95) per diluted share, compared with net income of $1.58 billion in the fourth quarter of 2023. For full-year 2024, net income attributable to common shareholders was $1.8 billion ($35.21 per diluted share), down from $2.5 billion in 2023, while operating income rose to $2.2 billion. The company also estimated a pre-tax net negative impact of approximately $750 million from the California wildfires in the first quarter of 2025.
Q4 2024 net loss of $198.5 million, or $(3.95) per diluted share, versus net income of $1.58 billion in Q4 2023
Full-year 2024 net income of $1.8 billion ($35.21 per diluted share) versus $2.5 billion in 2023; operating income of $2.2 billion ($42.99 per diluted share) versus $1.8 billion
Hurricane Milton had a net negative impact of $270.5 million on Q4 2024 net income
Estimated pre-tax net negative impact of approximately $750 million from the California wildfires in Q1 2025, based on a $50 billion aggregate industry insured loss
Trustmark reported fourth-quarter 2024 net income of $56.3 million, or $0.92 per diluted share, up $5.0 million from the prior quarter and up from $36.1 million a year earlier. The Board raised the regular quarterly dividend 4.3% to $0.24 per share and the company resumed share repurchases, buying back $7.5 million of stock in the quarter, which the company says reflects improved profitability and capital levels.
Q4 2024 net income $56.3 million, diluted EPS $0.92, up from $0.84 in Q3 2024 and $0.59 in Q4 2023 (total EPS)
Full-year 2024 net income from adjusted continuing operations was $186.3 million, or $3.04 per diluted share, up 17.0% from the prior year
Quarterly dividend increased to $0.24 from $0.23, payable March 15, 2025, to holders of record on March 1, 2025
A $100.0 million repurchase program is authorized from January 1 through December 31, 2025; deposits fell 3.0% year over year to $15.1 billion
BXP, Inc. reported a fourth-quarter 2024 net loss attributable to BXP of $230.0 million, or $1.45 per diluted share, compared with net income of $83.6 million, or $0.53 per share, in the prior quarter. The loss reflects impairment charges of about $341.3 million on investments in three unconsolidated joint ventures, while diluted FFO per share declined slightly to $1.79 from $1.81. Shareholders should note the impairment-driven loss and the 2025 guidance of $6.77 to $6.95 in diluted FFO per share.
Q4 2024 net loss attributable to BXP, Inc. of $230.0 million, or $1.45 per diluted share, versus $0.53 per share in Q3 2024
Impairment charges of about $341.3 million related to three unconsolidated joint ventures
Q4 2024 total revenue of $858.6 million versus $859.2 million in Q3 2024; diluted FFO per share of $1.79 versus $1.81
2025 guidance: full-year diluted FFO per share of $6.77 to $6.95 and first-quarter 2025 diluted FFO per share of $1.63 to $1.65
Clorox said Chief Financial Officer Kevin Jacobsen will retire effective April 1, 2025, after nearly 30 years with the company, and will advise through June 2025. Treasurer Luc Bellet, a Clorox employee since 2006, was appointed to succeed him as Executive Vice President and Chief Financial Officer effective the same day. The filing discloses a planned leadership transition with no financial results or guidance changes.
Kevin Jacobsen retires as CFO effective April 1, 2025; advisory role until June 2025
Luc Bellet, age 46, appointed EVP and CFO effective April 1, 2025; currently Vice President and Treasurer since October 2023
Bellet's base salary set at $725,000, with short-term incentive target raised from 50% to 100% of salary
Bellet to receive restricted stock units with $400,000 aggregate fair value and performance shares with $600,000 target fair value
Stride reported second-quarter fiscal 2025 revenue of $587.2 million, up 16.3%, and net income of $96.4 million, or $2.03 per diluted share, compared with $1.54 a year earlier. The company raised its full-year fiscal 2025 revenue forecast to $2.320 billion to $2.355 billion and its adjusted operating income forecast to $430 million to $450 million, which points to continued growth for shareholders.
Revenue of $587.2 million for the quarter ended December 31, 2024, compared with $504.9 million a year earlier
Net income of $96.4 million, or $2.03 per diluted share, versus $66.8 million, or $1.54 per diluted share
Full-year fiscal 2025 revenue outlook raised to $2.320 billion to $2.355 billion; adjusted operating income outlook of $430 million to $450 million
Second-quarter enrollments averaged 230.6K, up 19.4% from 193.1K a year earlier
CFO Shaun P. Mara notified the company on January 27, 2025, that he will retire effective July 3, 2025, and will remain CFO until then. The company hired Christopher J. Bealer, whose most recent executive role was EVP Corporate Controller at Reckitt, as Senior Vice President of Finance effective April 1, 2025, and he is expected to succeed Mara as CFO on July 3. The planned transition gives shareholders a roughly three-month overlap period before the handover.
Shaun P. Mara will retire as CFO effective July 3, 2025, and resign from all company positions then.
Christopher J. Bealer starts as Senior Vice President of Finance on April 1, 2025, and is expected to become CFO on July 3, 2025.
Bealer has almost 23 years of consumer packaged goods experience and most recently led a global team of over 600 employees at Reckitt.
At the January 23, 2025 annual meeting, all 11 director nominees were elected, and Deloitte & Touche LLP was ratified as auditor with 94,462,324 votes for.
F5 reported first-quarter fiscal 2025 revenue of $766 million, up 11% from $693 million a year earlier, and GAAP net income of $166 million, or $2.82 per diluted share, compared with $2.32 a year earlier. The company raised its fiscal 2025 revenue growth expectation to 6% to 7% from 4% to 5%, and its non-GAAP earnings per share growth expectation to 6.5% to 8.5% from 5% to 7%.
Revenue reached $766 million, up from $693 million; software revenue rose 22%, systems revenue rose 18%, and global services revenue rose 3%.
GAAP earnings were $2.82 per diluted share versus $2.32; non-GAAP earnings were $3.84 per diluted share versus $3.43.
Fiscal 2025 revenue growth guidance was raised to 6% to 7%, up from 4% to 5%.
Second-quarter fiscal 2025 guidance calls for revenue of $705 million to $725 million and non-GAAP earnings of $3.02 to $3.14 per diluted share.
Nextracker reported fiscal third-quarter 2025 results for the period ended December 31, 2024. Revenue fell year over year to $679 million and GAAP diluted EPS fell to $0.79 from $0.87, while adjusted diluted EPS rose to $1.03 from $0.96; the company raised its FY25 profit outlook and reaffirmed its revenue outlook of $2.8 billion to $2.9 billion.
Q3 FY25 revenue was $679 million, compared with $710 million in Q3 FY24 and $636 million in Q2 FY25.
GAAP diluted EPS was $0.79 versus $0.87 a year earlier; adjusted diluted EPS was $1.03 versus $0.96.
FY25 GAAP diluted EPS outlook was raised to $3.11 to $3.31 from $2.50 to $2.70; adjusted diluted EPS outlook to $3.75 to $3.95 from $3.10 to $3.30.
Q3 FY25 results included about $52 million of IRA 45X vendor rebates, which Q3 FY24 did not include.
Manhattan Associates reported fourth-quarter and full-year 2024 results that showed higher revenue and higher adjusted earnings per share than in 2023, while GAAP diluted EPS for the fourth quarter slipped to $0.77 from $0.78. The company's 2025 guidance projects GAAP EPS of $3.05 to $3.15 and adjusted EPS of $4.45 to $4.55, which the filing states are declines of 10% to 13% and 4% to 6%, respectively, from 2024.
Q4 2024 revenue was $255.8 million, up from $238.3 million in Q4 2023; Q4 GAAP diluted EPS was $0.77 versus $0.78, and adjusted diluted EPS was $1.17 versus $1.03.
Full-year 2024 revenue was $1,042.4 million, up from $928.7 million; GAAP diluted EPS was $3.51 versus $2.82.
2025 guidance: total revenue of $1,060 million to $1,070 million and adjusted EPS of $4.45 to $4.55.
In January 2025 the company eliminated about 100 positions and raised its share repurchase authority to $100.0 million.
U.S. Bancorp's board elected President Gunjan Kedia as chief executive officer effective April 15, 2025, and as a director, effective immediately. Andrew Cecere, the current chairman and CEO, will remain on the board as executive chairman. The filing sets no base salary or target bonus yet for Kedia, but it discloses a $10 million long-term incentive award, which is a planned leadership change that does not itself affect reported results.
Gunjan Kedia, 54, becomes President and CEO of U.S. Bancorp and U.S. Bank effective April 15, 2025
Andrew Cecere, CEO since April 2017 and chairman since April 2018, becomes executive chairman on April 15, 2025
Kedia's long-term incentive award is valued at $10 million as of the February 27, 2025 grant date, with 60% in performance-based restricted stock units
Base salary, target annual cash incentive for Kedia, and Cecere's executive chairman compensation have not been determined
General Motors reported a fourth-quarter 2024 net loss attributable to shareholders of $3.0 billion, reduced by more than $5 billion in special charges, including $4 billion of non-cash restructuring and China joint venture impairment charges and $0.5 billion tied to ending funding for the Cruise robotaxi business. Fourth-quarter revenue rose 11.0%, and full-year 2024 net income fell 40.7% to $6.0 billion, while 2025 net income guidance is $11.2 billion to $12.5 billion. For shareholders, strong operating measures are offset by large one-time charges and lower full-year GAAP profit.
Q4 2024 net loss attributable to stockholders of $3.0 billion; EPS-diluted was $(1.64) versus $1.59 a year earlier
Q4 2024 revenue rose 11.0% to $47.7 billion; EBIT-adjusted rose 42.8% to $2.5 billion
Full-year 2024 net income fell 40.7% to $6.0 billion; EBIT-adjusted rose 20.9% to $14.9 billion
2025 guidance: net income attributable to stockholders of $11.2 billion to $12.5 billion; EPS-diluted-adjusted of $11.00 to $12.00
Lantheus agreed to acquire Evergreen Theragnostics, a clinical-stage radiopharmaceutical company with a contract manufacturing business, for a $250 million cash upfront payment plus up to $752.5 million in milestone payments. The company also reaffirmed its full-year 2024 revenue and adjusted EPS guidance, and the deal is expected to close in the second half of 2025, subject to regulatory clearances.
Upfront cash payment of $250 million at closing, plus up to $752.5 million in milestone payments tied to OCTEVY and Evergreen's pipeline
Reaffirmed FY 2024 revenue guidance of $1.51 billion to $1.52 billion and adjusted fully diluted EPS guidance of $6.65 to $6.70
Closing expected in the second half of 2025; reverse termination fee of $10 million payable to Evergreen in certain regulatory-failure cases
Investor presentation says the deal is low single digit percent dilutive to Lantheus stand-alone EPS in the near term
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.